MD3987B1 - Utilizare a Diosminei pentru tratamentul cirozei hepatice avansate asociate cu insuficienta cardiaca - Google Patents
Utilizare a Diosminei pentru tratamentul cirozei hepatice avansate asociate cu insuficienta cardiacaInfo
- Publication number
- MD3987B1 MD3987B1 MDA20090104A MD20090104A MD3987B1 MD 3987 B1 MD3987 B1 MD 3987B1 MD A20090104 A MDA20090104 A MD A20090104A MD 20090104 A MD20090104 A MD 20090104A MD 3987 B1 MD3987 B1 MD 3987B1
- Authority
- MD
- Moldova
- Prior art keywords
- treatment
- diosmine
- advancing
- cirrhosis associated
- cardiac insufficiency
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 title abstract 3
- 208000019425 cirrhosis of liver Diseases 0.000 title abstract 3
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 title abstract 2
- 229960004352 diosmin Drugs 0.000 title abstract 2
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 abstract 1
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Inventia se refera la medicina, in special la hepatologie si poate fi utilizata pentru tratamentul pacientilor cu ciroza hepatica avansata asociata cu insuficienta cardiaca. Esenta inventiei consta in utilizarea Diosminei pentru tratamentul cirozei hepatice avansate asociate cu insuficienta cardiaca., care se administreaza per os cate 600 mg, de 1…2 ori pe zi, timp de 1…3 luni.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20090104A MD3987C2 (ro) | 2009-09-03 | 2009-09-03 | Utilizare a Diosminei pentru tratamentul cirozei hepatice avansate asociate cu insuficienţă cardiacă |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20090104A MD3987C2 (ro) | 2009-09-03 | 2009-09-03 | Utilizare a Diosminei pentru tratamentul cirozei hepatice avansate asociate cu insuficienţă cardiacă |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD3987B1 true MD3987B1 (ro) | 2009-12-31 |
| MD3987C2 MD3987C2 (ro) | 2010-07-31 |
Family
ID=43568856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20090104A MD3987C2 (ro) | 2009-09-03 | 2009-09-03 | Utilizare a Diosminei pentru tratamentul cirozei hepatice avansate asociate cu insuficienţă cardiacă |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD3987C2 (ro) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD4232C1 (ro) * | 2012-11-08 | 2014-01-31 | Георге АНГЕЛИЧ | Remediu medicamentos pe bază de troxerutin şi carbazocrom pentru tratamentul cirozei hepatice avansate asociate cu insuficienţă cardiacă |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0174958B1 (en) * | 1984-03-01 | 1991-12-18 | Lamorna Investments Proprietary Limited | Treatment of high protein oedemas by direct application of benzo-pyrones |
| CH671021A5 (en) * | 1987-05-07 | 1989-07-31 | Espanola Prod Quimicos | Prodn. of hydroxy:ethylated diosmin mixts. - useful for treating intoxication |
| FR2661610B1 (fr) * | 1990-05-02 | 1994-09-30 | Rhone Poulenc Sante | Nouvelle forme lyophilisee de la diosmine et sa preparation. |
| FR2661830B1 (fr) * | 1990-05-11 | 1992-09-04 | Corbiere Jerome | Nouvelle compositions pharmaceutiques a base de flavonoside. |
| FR2668705A1 (fr) * | 1990-11-06 | 1992-05-07 | Bouchara Sa | Nouvelles preparations dermiques a action phlebotonique et leur procede de preparation. |
| FR2692145B1 (fr) * | 1992-06-10 | 1995-05-05 | Bellon Labor Sa Roger | Nouvelle composition à usage topique contenant de la diosmine. |
| FR2726469B1 (fr) * | 1994-11-08 | 1996-12-13 | Adir | Composition pharmaceutique pour l'administration orale de flavonoides |
| JPH08301757A (ja) * | 1995-05-10 | 1996-11-19 | Kureha Chem Ind Co Ltd | Hsp47合成抑制剤 |
| BE1011151A3 (fr) * | 1997-05-13 | 1999-05-04 | Jose Remacle | Utilisation d'une composition pharmaceutique dans le traitement et/ou la prevention de l'ischemie. |
| FR2778663B1 (fr) * | 1998-05-15 | 2001-05-18 | Coletica | Nouveaux esters de flavonoides,leur utilisation en cosmetique, dermopharmacie, en pharmacie et en agro-alimentaire |
| JP2000023635A (ja) * | 1998-07-10 | 2000-01-25 | M P G Kk | 粉粒体栄養補助食品 |
| KR20000019717A (ko) * | 1998-09-15 | 2000-04-15 | 박호군 | 루틴 및 쿼세틴을 포함하는 고지혈증, 동맥경화증 및 간 질환의예방 및 치료용 조성물 |
| KR100291141B1 (ko) * | 1998-09-15 | 2001-07-12 | 박호군 | 디오스민을포함하는동맥경화증및고지혈증의예방및치료용조성물 |
| CA2425912A1 (en) * | 2000-09-11 | 2002-03-14 | Michael D. Stander | Use of buchu extracts for hypertension |
| KR100291144B1 (ko) * | 2000-10-06 | 2001-05-15 | 박호군 | 디오스민을 포함하는 동맥경화증 및 고지혈증의 예방 및치료용 조성물 |
| KR100291145B1 (ko) * | 2000-10-06 | 2001-05-15 | 박호군 | 네오헤스페리딘 디하이드로칼콘을 포함하는 동맥경화증,고지혈증, 간 질환, 고혈당증의 예방 및 치료용 조성물 |
| FR2845597B1 (fr) * | 2002-10-11 | 2005-03-11 | Innothera Lab Sa | Formulation orale seche contenant de la diosmine sous forme pharmaceutique de comprime a croquer |
| US20040132816A1 (en) * | 2003-01-06 | 2004-07-08 | Liao Medical Corporation | Lipid metabolism and fructus crataegus |
| FR2857665B1 (fr) * | 2003-07-16 | 2006-02-10 | Centre Nat Rech Scient | Nouveaux derives de flavones, leur procede de preparation et compositions pharmaceutiques les contenant |
| ITMI20050517A1 (it) * | 2005-03-30 | 2006-09-30 | Therapicon Srl | Composizione farmaceutica di una tipica frazione microcristallina di flavonoidi |
| CN100444847C (zh) * | 2006-01-11 | 2008-12-24 | 刘展欣 | 一种微粒化地奥司明和橙皮甙组合物栓剂 |
| MX2007011002A (es) * | 2007-09-07 | 2009-03-09 | World Trade Imp Export Wtie Ag | Composicion farmaceutica que comprende la combinacion de diversos agentes venotonicos y vasoprotectores para el tratamiento de la insuficiencia venosa cronica. |
-
2009
- 2009-09-03 MD MDA20090104A patent/MD3987C2/ro not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD3987C2 (ro) | 2010-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR11749A (es) | Tratamiento de la disnea asociada con insuficiencia cardiaca aguda con relaxina | |
| MA38399A1 (fr) | Formulation sous forme de comprimé, utile pour traiter l'insuffisance cardiaque aiguë et l'insuffisance cardiaque chronique | |
| EA201401028A1 (ru) | Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения | |
| CL2012002037A1 (es) | Uso de agonista doble del glucagon-glp-1 como agente inotropico en el tratamiento de la cardiopatía o la disfuncion cardiaca | |
| MX2013007189A (es) | Metodos y composiciones adecuados para manejar glucosa en sangre en animales. | |
| PA8794401A1 (es) | Acidos 6-fenilnicotinicos sustituidos y su uso | |
| Ellis | The effects of sympathomimetic amines and adrenergic blocking agents on metabolism | |
| MX2016011333A (es) | Sistemas de administracion de farmaco y metodo para el tratamiento de cancer de vejiga con gemcitabina. | |
| MX367209B (es) | Una composición intravenosa que comprende ibuprofeno y paracetamol en combinación. | |
| BR112015010039A2 (pt) | tratamento de câncer com pomalidomida em um individuo com disfunção renal | |
| CO2017003263A2 (es) | Composición farmacéutica basadas en anamorelina que tienen actividad sobre caquexia causada por cáncer | |
| AR103415A1 (es) | Tratamiento de pacientes pediátricos con diabetes mellitus de tipo 2 | |
| PE20181332A1 (es) | Metodos de sedacion y formulacion parenteral para uso durante el tratamiento de cuidados criticos | |
| BR112013033544A2 (pt) | dosagem e administração de anticorpos anti-erbb3 em combinação com paclitaxel para tratamento de cânceres ginecológicos | |
| EA201071209A1 (ru) | Применение дронедарона или его фармацевтически приемлемой соли для получения лекарственного средства для регуляции уровня калия в крови | |
| MX386476B (es) | Agente estimulador del receptor 1b de 5-hidroxitriptamina para mejorar el potencial de injerto in vivo. | |
| TR201200950T1 (tr) | İlerlemiş meme kanseri tedavisi için 500 mg'lik bir dozajda fulvestrant. | |
| MD3987B1 (ro) | Utilizare a Diosminei pentru tratamentul cirozei hepatice avansate asociate cu insuficienta cardiaca | |
| AR077427A1 (es) | Otamixaban para el tratamiento de pacientes con alteracion renal y de edad avanzada con infarto de miocardio sin elevacion del st | |
| MX387263B (es) | Composición farmacéutica de liberación prolongada que comprende cisteamina o sal de la misma. | |
| CL2009001221A1 (es) | Uso de un androgeno y/o un modulador selectivo del receptor de androgeno para preparar un medicamento para el tratamiento de la insuficiencia cardiaca o para retardar o detener el avance de la insuficiencia cardiaca en un sujeto humano de sexo femenino. | |
| MD3986B1 (ro) | Utilizare a Diosminei pentru tratamentul gastropatiilor portale in ciroza hepatica | |
| EA201590732A1 (ru) | Диспергируемая таблетка | |
| ES2468665B1 (es) | Composición farmacéutica de sulfato de condroitina y celecoxib | |
| MD4232B1 (ro) | Remediu medicamentos pe baza de troxerutin si carbazocrom pentru tratamentul cirozei hepatice avansate asociate cu insuficienta cardiaca |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |